We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DOJ, SEC Reach Deal In Drug Maker's Insider-Trading

Law360 (March 9, 2007, 12:00 AM EST) -- Federal prosecutors and securities regulators have wrapped up parallel cases against a former executive at bankrupt generic drug maker Able Laboratories Inc., after accusing him of insider-trading in a scheme to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.